Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $171.00 billion as of March 6, 2026. Its market cap has decreased by -53.22% in one year.

Market Cap

171.00B

Enterprise Value

187.15B

Revenue

48.59B

Ranking

n/a

PE Ratio

10.62

Stock Price

$38.41

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 171.00B, an increase of 2,292.80%. That is a compound annual growth rate of 11.54%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	171.00B	-24.88%
Dec 30, 2025	227.63B	-41.00%
Dec 30, 2024	385.82B	-16.41%
Dec 29, 2023	461.55B	51.61%
Dec 30, 2022	304.43B	19.34%
Dec 30, 2021	255.09B	56.58%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	791.42M
Veradigm	724.25M
Glass House Brands	659.67M
Elite Pharmaceuticals	420.20M
American Oncology Network	389.18M
Northwest Biotherapeutics	361.40M
CytoDyn	310.14M
Silence Therapeutics	273.01M

Market Cap Rankings